Items tagged with Access
Drug price transparency: 10 countries back World Health Assembly resolution (post)
Ten countries, including five European Union (EU) member states, have now lined up in support of a landmark resolution to increase transparency of drug prices globally, which is expected to be a key focus of deliberations by WHO member states as they convene for the 72nd World Health Assembly (WHA), May 20-28 in Geneva.
Ensuring access to life-saving medicines as countries shift from Global Fund support (post)
An editorial published in the Bulletin of the World Health Organization explains the risks related to the quality, affordability and supply of HIV and TB medical commodities with the shift from Global Fund-supported pooled procurement to national systems.
Several developed countries want to “derail” transparency resolution – civil society groups say (post)
More than 100 civil society organisations and health experts signed on to an open letter yesterday calling out Germany, Sweden, Denmark, the UK and Australia, along with Austria and the United States, as wanting to “derail” and “weaken” the transparency resolution on drug prices and R&D costs.
Health Policy Watch makes latest text of WHO transparency resolution open access (post)
Health Policy Watch is publishing in an open-access format the latest draft of the World Health Assembly resolution on transparency of drug costs. The new draft, now available to all, reflects changes from the 10 May closed-door informal negotiations at the WHO, and shows progress toward compromise among member states.
New study from Access to Medicine Foundation analyses 10 years of data on pharma companies and access to medicine (post)
In a new report the Access to Medicine Foundation shows where pharmaceutical companies have made progress in the past ten years when it comes to access to medicine. It analyses companies’ performances in 106 low- and middle-income countries – home to 83% of all people alive today.
High prevalence of stockouts of antiretroviral and TB medicines in South Africa (post)
One in five public health facilities in South Africa were unable to supply at least one antiretroviral (ARV) or tuberculosis (TB) drug on the day they were contacted by researchers, while over a third had had a drug stockout in the previous three months, according to a national survey published in PLOS ONE.
Threat of compulsory licences could increase access to essential medicines (post)
In an analysis, published in The BMJ, Gorik Ooms and Johanna Hanefeld argue that low- and middle-income countries could increase access to medicines by forming an alliance to credibly threaten companies with compulsory licences.
Six international organizations pledge collaboration on local production of medicines (post)
The World Health Organization, the UN Industrial Development Organization (UNIDO), the UN Conference on Trade and Development (UNCTAD), UNAIDS, UNICEF, and the Global Fund co-signed the “Interagency statement on promoting local production of medicines and other health-related technologies.”
World Health Assembly approves milestone resolution on price transparency (post)
28 May 2019: The World Health Assembly today approved a milestone resolution to support greater public disclosure of prices for medicines and other health products – capping a nail-biting series of negotiations that continued until the very moment the measure came to the floor.
Treatment is free, yet 1 in 4 Indian TB patients must sell assets or borrow money (post)
New Delhi: One in four tuberculosis (TB) patients had to sell assets or borrow money--that is, resort to ‘hardship financing’--to pay for their treatment, a new study has shown.
Page 38 of 83 · Total posts: 0
←First 37 38 39 Last→